ChBE Seminar Series: Bryan Berger

Friday, December 6, 2013
10:00 a.m.-11:00 a.m.
Room 2108, Chemical and Nuclear Enginering Bldg.
Professor Jeffery Klauda
jbklauda@umd.edu

Sequence, Structure and Specificity in Transmembrane Signal Transduction

Bryan Berger
Assistant Professor
Dept. of Chemical Engineering
Lehigh University

Introduction
Protein-protein and protein-lipid interactions in membranes play a critical role in regulating transmembrane signal transduction. Receptors, channels and other integral membrane proteins reside in equilibrium between resting and active, ligand-bound state, the latter of which is responsible for activating distinct intracellular signaling pathways. A key mechanism by which this equilibrium is regulated is through transmembrane-mediated receptor oligomerization. We are interested in studying the regulated oligomerization of a class of membrane co-receptors, receptor activity modifying proteins (RAMPs), with the G-protein coupled receptor calcitonin-like receptor (CLR) during early heart development, focusing on the role of transmembrane domain interactions in regulating signaling. RAMP1-CLR plays numerous roles in heart development and vascular maintenance in adults, and dysregulation of the RAMP1-CLR signaling has been linked to numerous disease states, including acute migraines and acute coronary syndrome (ACS), and small-molecule therapeutics targeting CLR-RAMP heterooligomers are currently in clinical trials as a treatment for migraines. Thus, understanding the structural basis for CLR-RAMP heterooligomerization is central to understanding the basis for CLR signaling in vascular development as well as in developing effective approaches to treating diseases associated with CLR.

Results and Discussion
Using sequence-directed searches of transmembrane structural databases, we identified multiple interfaces common to all co-receptors and CLR and developed a model linking these interfaces to the ability to heterooligomerize with CLR. To validate this model, we developed a series novel, cell-based assays (Su and Berger, JBC 2012; Su and Berger, JMB 2013) that enable characterization of homo- and heterodimeric interfaces for single transmembrane helices in cell membranes, and used these assays for RAMP1-CLR. Biochemically, we confirmed the importance of the proposed heterodimeric interface in transfected cells by monitoring cAMP expression levels and in vivo FRET measurements, all of which demonstrated that targeted mutations to the predicted interface inhibited oligomerization of RAMP-CLR and attenuated cAMP expression. MO-mediated knockdown and RAMP1 rescue studies using zebrafish also confirm the importance of RAMP1 as well as the key role of the predicted interface in regulating multiple, distinct signaling events during cardiovascular development.

Conclusions
Overall, our results point to a central role for transmembrane-mediated interactions in regulating RAMP1-CLR heterooligomerization as well as a specific interface responsible for regulating signaling. Our current and future work is focused on implementing a robust, large-scale expression system (Su et al., Protein Science 2013) that will allow us to investigate in detail the structural basis for RAMP1-CLR heterooligomerization, which will give us greater insight into the molecular details of transmembrane-mediated CLR signaling, as well as design and characterization of peptide mimics that target the RAMP1-CLR interface.

Audience: Graduate  Faculty  Post-Docs 

 

August 2019

SU MO TU WE TH FR SA
28 29 30 31 1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31
1 2 3 4 5 6 7
Submit an Event